BioRestorative Therapies issues Q2 2025 earnings; no figures in provided excerpt

BioRestorative Therapies, Inc.

2025-Q2 EPS reported -$0.94 revenue$328,300

Press release dated Aug 12, 2025 announces Q2 financial results and a business update.
Conference call scheduled to discuss the results; details in the press release.
Specific revenue, EPS, and segment data not included in the filing text provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.